404 related articles for article (PubMed ID: 16425024)
1. Kappa light chain myeloma with initial cutaneous involvement.
Saka B; Erten N; Oztürk G; Yilmaz C; Dogan O; Buyukbabani N; Besisik SK
Ann Hematol; 2006 Apr; 85(4):272-4. PubMed ID: 16425024
[No Abstract] [Full Text] [Related]
2. A case of aggressive multiple myeloma with cleaved, multilobated, and monocytoid nuclei, and no serum monoclonal gammopathy.
Yeh YA; Pappas AA; Flick JT; Butch AW
Ann Clin Lab Sci; 2000 Jul; 30(3):283-8. PubMed ID: 10945569
[TBL] [Abstract][Full Text] [Related]
3. IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.
Chiu W; Pullon H; Woon ST; Oei P; The R; Ameratunga R
Pathology; 2010 Jan; 42(1):82-4. PubMed ID: 20025486
[No Abstract] [Full Text] [Related]
4. Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.
Huston A; Brown J; Roodman GD
Exp Hematol; 2006 Dec; 34(12):1616. PubMed ID: 17157156
[No Abstract] [Full Text] [Related]
5. Fatal sepsis after thalidomide/dexamethasone treatment in two patients with multiple myeloma.
Wölfler A; Bauer F; Zollner G; Weber K; Sill H; Linkesch W
Haematologica; 2003 Apr; 88(4):ELT12. PubMed ID: 12681989
[No Abstract] [Full Text] [Related]
6. Acute leukemia of plasmablastic type as terminal phase of multiple myeloma.
Piccinini L; Artusi T; Bonacorsi G; Arigliano V
Haematologica; 2002 Feb; 87(2):EIM04. PubMed ID: 11836178
[No Abstract] [Full Text] [Related]
7. Two cases of plasma cell leukemia with atypical immunophenotype.
Buda G; Carulli G; Orciuolo E; Cannizzo E; Zucca A; Azzarà A; Rossi A; Galimberti S; Cecconi N; Petrini M
Acta Haematol; 2007; 118(1):27-9. PubMed ID: 17429194
[No Abstract] [Full Text] [Related]
8. Thalidomide and dexamethasone therapy of myeloma in a patient with previously untreated B-chronic lymphocytic leukemia.
Barton JC
Am J Hematol; 2003 Nov; 74(3):205-7. PubMed ID: 14587053
[TBL] [Abstract][Full Text] [Related]
9. Bortezomib in multiple myeloma: treatment and retreatment. A single center experience.
Warzocha K; Kraj M; Pogłód R; Kwaśniak B
Acta Pol Pharm; 2008; 65(6):753-6. PubMed ID: 19172860
[No Abstract] [Full Text] [Related]
10. Toxic epidermal necrolysis following thalidomide and dexamethasone treatment for multiple myeloma: a case report.
Eo WK; Kim SH; Cheon SH; Lee SH; Jeong JS; Kim YS; Chang HK; Suh KS; Kim HY
Ann Hematol; 2010 Apr; 89(4):421-2. PubMed ID: 19693501
[No Abstract] [Full Text] [Related]
11. [Primary plasma cell leukemia (IgD-lambda) with hyperammonemia].
Minauchi K; Fujie T; Matsubara N; Kasahara H; Ogura Y; Tamura M; Yamane Y; Tanaka M; Taneichi K
Nihon Naika Gakkai Zasshi; 2004 Jan; 93(1):139-41. PubMed ID: 14968586
[No Abstract] [Full Text] [Related]
12. Efficacy of bortezomib, lenalidomide and dexamethasone (VRD) in secondary plasma cell leukaemia.
Gozzetti A; Musto P; Defina M; D'Auria F; Papini G; Statuto T; D'Arena G; Bocchia M
Br J Haematol; 2012 May; 157(4):497-8. PubMed ID: 22296516
[No Abstract] [Full Text] [Related]
13. Cutaneous involvement in multiple myeloma and bortezomib.
Siniscalchi A; Fratoni S; Santeusanio G; Del Poeta G; de Fabritiis P; Caravita T
Ann Hematol; 2009 Nov; 88(11):1137-9. PubMed ID: 19259673
[No Abstract] [Full Text] [Related]
14. [Plasmocytic pleural effusion disclosing multiple myeloma].
Elloumi M; Frikha M; Masmoudi H; Mseddi S; Ben Ayed M; Bouaziz M; Makni F; Souissi T
Rev Mal Respir; 2000 Apr; 17(2):495-7. PubMed ID: 10859769
[TBL] [Abstract][Full Text] [Related]
15. Clarithromycin with low dose dexamethasone and thalidomide is effective therapy in relapsed/refractory myeloma.
Morris TC; Kettle PJ; Drake M; Jones FC; Hull DR; Boyd K; Morrison A; Clarke P; O'Reilly P; Quinn J
Br J Haematol; 2008 Nov; 143(3):349-54. PubMed ID: 18759764
[TBL] [Abstract][Full Text] [Related]
16. Rapid complete remission in multiple myeloma with bortezomib/thalidomide/dexamethasone combination therapy following development of tumor lysis syndrome.
Chim CS
Cancer Chemother Pharmacol; 2008 Jun; 62(1):181-2. PubMed ID: 17846773
[No Abstract] [Full Text] [Related]
17. Lenalidomide and its role in the management of multiple myeloma.
Falco P; Cavallo F; Larocca A; Liberati AM; Musto P; Boccadoro M; Palumbo A
Expert Rev Anticancer Ther; 2008 Jun; 8(6):865-74. PubMed ID: 18533796
[TBL] [Abstract][Full Text] [Related]
18. Meningeal Myelomatosis.
DeFilipp Z; Sahovic EA; Nooka AK
J Oncol Pract; 2016 Feb; 12(2):187-8. PubMed ID: 26869657
[No Abstract] [Full Text] [Related]
19. Coexistence of chronic neutrophilic leukemia with light chain myeloma.
Cehreli C; Undar B; Akkoc N; Onvural B; Altungoz O
Acta Haematol; 1994; 91(1):32-4. PubMed ID: 8171934
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide paradoxical effect on concomitant multiple myeloma and myelodysplasia.
Badros A; Morris C; Zangari M; Barlogie B; Tricot G
Leuk Lymphoma; 2002 Jun; 43(6):1267-71. PubMed ID: 12152995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
